Bronchitol mannitol regulatory update

Pharmaxis resubmitted an application to Australia's Pharmaceutical Benefits Advisory Committee (PBAC) for cystic fibrosis drug Bronchitol mannitol to be included for reimbursement on the Australian Ph...